Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 122781 - 122800 out of 563841 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Canada | (L01XE06) dasatinib | Sprycel | Tab/Co. Orl 70 mg,Tablet / comprimé | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRI |
| Canada | (L01XE06) dasatinib | Sprycel | Tab/Co. Orl 80 mg,Tablet / comprimé | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRI |
| Canada | (L01XE06) dasatinib | Sprycel | Tab/Co. Orl 100 mg,Tablet / comprimé | Wholesale price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | BRI |
| Canada | (L01XE24) ponatinib | Iclusig | Tab/Co. Orl 15 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid; Leukemia, Lymphoid | TAK |
| Canada | (L01XE24) ponatinib | Iclusig | Tab/Co. Orl 45 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid; Leukemia, Lymphoid | TAK |
| Canada | (L01XE26) cabozantinib | Cabometyx | Tab/Co. Orl 20 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Carcinomas, Hepatocellular | IPS |
| Canada | (L01XE26) cabozantinib | Cabometyx | Tab/Co. Orl 40 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Carcinomas, Hepatocellular | IPS |
| Canada | (L01XE26) cabozantinib | Cabometyx | Tab/Co. Orl 60 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Carcinomas, Hepatocellular | IPS |
| Canada | (L01XE33) palbociclib | Ibrance | Cap/Caps Orl 75 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PFI |
| Canada | (L01XE33) palbociclib | Ibrance | Cap/Caps Orl 100 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PFI |
| Canada | (L01XE33) palbociclib | Ibrance | Cap/Caps Orl 125 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PFI |
| Canada | (L01XE24) ponatinib | Iclusig | Tab/Co. Orl 15 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid; Leukemia, Lymphoid | TAK |
| Canada | (L01XE39) midostaurin | Rydapt | Cap/Caps Orl 25 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute; Mastocytosis | NVR |
| Canada | (L01XE24) ponatinib | Iclusig | Tab/Co. Orl 45 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid; Leukemia, Lymphoid | TAK |
| Canada | (L01XE26) cabozantinib | Cabometyx | Tab/Co. Orl 20 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Carcinomas, Hepatocellular | IPS |
| Canada | (L01XE26) cabozantinib | Cabometyx | Tab/Co. Orl 40 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Carcinomas, Hepatocellular | IPS |
| Canada | (L01XE26) cabozantinib | Cabometyx | Tab/Co. Orl 60 mg,Tablet / comprimé | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Carcinomas, Hepatocellular | IPS |
| Canada | (L01XE31) nintedanib | Ofev | Cap/Caps Orl 100 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis | BOE |
| Canada | (L01XE31) nintedanib | Ofev | Cap/Caps Orl 150 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis | BOE |
| Canada | (L01XE33) palbociclib | Ibrance | Cap/Caps Orl 75 mg,Capsule / capsule | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | PFI |
Pages
